Concord Medical Services Holdings Limited
CCM · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 472.09M | -152.41M | -525.05M | -489.66M | -3.36K |
| 2023 FY | 537.40M | -76.61M | -462.99M | -297.66M | -2.04K |
| 2024 FY | 383.96M | -79.16M | -532.16M | -308.24M | -2.12K |
| 2025 FY | 460.51M | 25.82M | -239.33M | -92.81M | -621.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 6.00B | 3.99B | 158.28M | 3.24B | -1.86B |
| 2023 FY | 6.05B | 4.31B | 58.14M | 3.30B | -2.12B |
| 2024 FY | 6.73B | 5.11B | 216.22M | 3.93B | -2.28B |
| 2025 FY | 6.55B | 4.70B | 297.79M | 3.63B | -2.10B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -216.69M | -383.77M | -600.47M | — | 432.00K |
| 2023 FY | -276.47M | -115.70M | -392.17M | — | -68.92M |
| 2024 FY | -397.75M | -410.83M | -808.58M | — | 146.56M |
| 2025 FY | -201.82M | -91.33M | -293.16M | — | 61.73M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 16.47M | 3.10B | — | — | — |
| 2023 FY | 11.88M | 3.25B | — | — | — |
| 2024 FY | 5.72M | 3.72B | — | — | — |
| 2025 FY | 3.93M | 3.34B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q1 | 100.31M | -2.14M | -72.33M | -13.57M | -93.30 |
| 2025 Q2 | 100.31M | -2.14M | -72.33M | -13.57M | -93.30 |
| 2025 Q3 | 129.95M | 15.05M | -1.75M | -32.84M | -225.60 |
| 2025 Q4 | 255.10M | 29.55M | -92.93M | -64.46M | -444.60 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q1 | 6.73B | 5.01B | 177.39M | 3.82B | -2.24B |
| 2025 Q2 | 6.73B | 5.01B | 177.39M | 3.82B | -2.24B |
| 2025 Q3 | 6.55B | 4.70B | 297.79M | 3.63B | -2.10B |
| 2025 Q4 | 6.55B | 4.70B | 297.79M | 3.63B | -2.10B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q1 | — | — | — | — | — |
| 2025 Q2 | — | — | — | — | — |
| 2025 Q3 | — | — | — | — | — |
| 2025 Q4 | — | — | — | — | — |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q1 | 4.17M | 3.65B | — | — | — |
| 2025 Q2 | 5.89M | 3.65B | — | — | — |
| 2025 Q3 | 6.36M | 3.34B | — | — | — |
| 2025 Q4 | 3.91M | 3.34B | — | — | — |